Zentalis Pharmaceuticals has recently disclosed the granting of inducements under Nasdaq Listing Rule 5635(c)(4). This announcement was made by the company through GlobeNewswire. The purpose of these inducements is to attract and retain key employees who are crucial to the success of the company. Zentalis Pharmaceuticals is dedicated to supporting and incentivizing its valuable team members to drive the company’s growth and innovation.
Subscribe
Login
0 Comments